Status | Study |
Recruiting |
Study Name: Tissue Repository: CTCL Collection Protocol Condition: Lymphoma, T-Cell, Cutaneous Lymphomatoid Papulosis Date: 2016-07-15 |
Active, not recruiting |
Study Name: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) Condition: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma Lymphoma, Primary Cutaneous Anapla Date: 2011-05-10 Interventions: Drug: SGN-35 1.8 mg/kg administered by outpatient IV infusion given over approximately 30 minutes on Day |
Completed |
Study Name: Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma Condition: Large Cell Lymphoma Date: 2004-12-10 Interventions: Drug: SGN-30 |